Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Looked To Arava’s Safety Experience In Gauging Aubagio’s Risks

Mar 19 2013

• By Sue Sutter

Related Content

Aventis Arava Labeling Update Expected Based On Methotrexate Combo Study

Sep 16 2002

<em>Aubagio</em> Approval Reflects FDA’s Evolving View On Multiple Sclerosis Drugs

Mar 19 2013

Aventis Arava Adds Physical Function Claim, Bolded Liver Safety Warning

Jun 23 2003

Aventis Arava Liver Toxicity Warning Is Satisfactory, FDA Arthritis Cmte. Says

Mar 10 2003

Arava, Avandia's Divergent Paths: FDA Strengthens Arava Label Warning

Jul 16 2010

Related Companies

Sanofi

Additional Topics

United States BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window